Neuroendocrine Tumors of the Lung

Written by J. GuanJan 2, 20242 min read
Woman Holding Chest Lung Illustration

Source: Shutterstock

The information below will provide relevant insights to help you better understand a group of lung tumors that grow from specialized lung cells called neuroendocrine cells. By learning more about it, your uncertainty may be alleviated.

Several types of lung tumors that fall in this category:

In general, lung neuroendocrine tumors (NETs) make up approximately 20% of all lung cancer cases. Among them, SCLC constitutes around 15%, lung carcinoids about 2% and LCNEC about 3%.

What are lung NETs?

Neuroendocrine tumors develop from hormone-producing cells of the neuroendocrine system. These cells are made up of nerves (‘neuro’ means nerve) and gland (‘endocrine’ refers to hormone system) cells. They are found in body organs that require precise regulation in response to changes in body functions or activities. For example, neuroendocrine cells of the food pipe (esophagus), stomach and intestines make hormones to control food movement and digestion.

Lung neuroendocrine cells produce hormones that regulate air exchange and blood flow in the lungs. A tumor develops when they grow out of control and turn cancerous.

Scientists subtype lung NETs based on their

  • Cell size and shape
  • The number of dividing or proliferating cells
  • Presence of necrosis (cell death)

These factors gave the different NET subtypes

  • Different levels of aggressiveness and
  • Different responses to chemotherapy

Risk factors

Scientists are not sure what causes lung NETs, although some risk factors are associated with certain lung cancer subtypes:

  • LCNEC and SCLC are commonly observed in smokers or ex-smokers
  • Almost all lung NETs are sporadic. Very rarely, some people develop lung NETs for inheriting genetic abnormalities in the MEN1 (Multiple Endocrine Neoplasia Type 1) gene
  • On average, the age at diagnosis for typical carcinoid tumor is 45 years and 55 years for atypical carcinoid tumor. This is slightly younger than the average diagnosis age for other subtypes of lung cancer

Symptoms

The symptoms of lung NETs are

Share this article:

This article has been medically reviewed and fact-checked to ensure our content is informed by the latest research in cancer, global and nationwide guidelines and clinical practice.

Click here for more information.

Explore Cancer Stories

A collection of informative and empowering stories by our users, sharing their journey from diagnosis, treatment to impact to their life.
Ian Profile
Wei Ying, 34
Undergoing treatment
Singapore

I lost my dad to cancer, and when I started showing similar symptoms, my mum urged me to visit the doctor. Eventually, I was diagnosed with stage 2 lung cancer.

Read More >
Sahil Profile
Sahil, 67
Undergoing treatment
India

My advice to anyone else facing cancer is this: it is scary. But it’s important to be strong for your loved ones.

Read More >
Kila Profile
Kila, 60
Undergoing treatment
Singapore

After a regular check-up at the hospital, the doctor advised that I should undergo more tests. I felt something was wrong and true enough, I was eventually diagnosed.

Read More >
Chan Profile
Sik Mun, 65
In remission
Singapore

It begins with a strange fatigue, the kind where climbing stairs felt impossible. That led to a diagnosis of Stage 4 lung cancer.

Read More >
Vikas Profile
Vikas, 56
Undergoing treatment
India

Hearing the news that I indeed have lung cancer overwhelmed me with sadness. I couldn’t shake off the feelings of disappointment, grief and emptiness that plagued me.

Read More >
Arman Profile
Arman, 37
Cancer-free
India

Throughout my recovery, my biggest fear was having a difficult and slow recovery. For this reason, I was impatient and constantly hoping for recovery to be quick.

Read More >
Kavish Profile
Anu, 59
Undergoing treatment
Singapore

Throughout my journey, my biggest fear was leaving behind my family members, especially my youngest daughter.

Read More >
Your story could inspire others facing similar challenges.